Legend Biotech Corp Other Finance Income
Legend Biotech Corp (LEGN) reported Other Finance Income of $601.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-11.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherFinanceIncome · last filed 2025-03-11
- Legend Biotech Corp other finance income for the quarter ending 2024-12-31 was $366.00K, a 52.50% increase year-over-year.
- Legend Biotech Corp other finance income for the quarter ending 2024-09-30 was $79.00K, a 7800.00% increase year-over-year.
- Legend Biotech Corp other finance income for the quarter ending 2024-06-30 was $56.00K.
- Legend Biotech Corp other finance income for the quarter ending 2024-03-31 was $100.00K, a 244.83% increase year-over-year.
| Period end | Other Finance Income 3 month | Other Finance Income 6 month | Other Finance Income 9 month | Other Finance Income 12 month |
|---|---|---|---|---|
| 2024-12-31 | $366.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $445.00K derived: sum of 2 quarters · filed 2025-03-11 | $501.00K derived: sum of 3 quarters · filed 2025-03-11 | $601.00K 20-F · filed 2025-03-11 |
| 2024-09-30 | $79.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $135.00K derived: sum of 2 quarters · filed 2024-11-12 | $235.00K 6-K · filed 2024-11-12 | $475.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-06-30 | $56.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $156.00K 6-K · filed 2024-08-09 | $396.00K derived: sum of 3 quarters · filed 2025-03-11 | $397.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2024-03-31 | $100.00K 6-K · filed 2024-05-13 | $340.00K derived: sum of 2 quarters · filed 2025-03-11 | $341.00K derived: sum of 3 quarters · filed 2025-03-11 | $316.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-12-31 | $240.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $241.00K derived: sum of 2 quarters · filed 2025-03-11 | $216.00K derived: sum of 3 quarters · filed 2025-03-11 | $245.00K 20-F · filed 2025-03-11 |
| 2023-09-30 | $1.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$24.00K derived: sum of 2 quarters · filed 2024-11-12 | $5.00K 6-K · filed 2024-11-12 | $2.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$25.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $4.00K 6-K · filed 2024-08-09 | $1.00K derived: sum of 3 quarters · filed 2025-03-11 | $90.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $29.00K 6-K · filed 2024-05-13 | $26.00K derived: sum of 2 quarters · filed 2025-03-11 | $115.00K derived: sum of 3 quarters · filed 2025-03-11 | |
| 2022-12-31 | -$3.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $86.00K derived: sum of 2 quarters · filed 2025-03-11 | $88.00K 20-F · filed 2025-03-11 | |
| 2022-09-30 | $89.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $91.00K 6-K · filed 2023-11-20 | ||
| 2022-06-30 | $2.00K 6-K · filed 2023-08-15 | |||
| 2021-12-31 | $35.00K 20-F · filed 2024-03-19 | |||
| 2021-06-30 | $832.00K 6-K · filed 2021-08-23 | |||
| 2020-12-31 | $4.00K 20-F · filed 2023-03-30 | |||
| 2019-12-31 | $138.00K 20-F/A · filed 2023-02-17 |